Karuna Therapeutics, Inc.

JPMORGAN CHASE & CO

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/12/2024

Shares

30,552

Value ($000)

9,670

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/12/2024	9,670	0.0%	30,552	12/31/2023
2023 Q3	11/14/2023	5,787	0.0%	34,227	9/30/2023
2023 Q2	8/11/2023	13,389	0.0%	61,743	6/30/2023
2023 Q1	5/18/2023	9,564	0.0%	52,657	3/31/2023
2022 Q4	2/13/2023	7,195	0.0%	36,612	12/31/2022
2022 Q3	11/14/2022	7,489	0.0%	33,297	9/30/2022
2022 Q2	8/11/2022	3,031	0.0%	23,966	6/30/2022
2022 Q1	5/11/2022	2,563	0.0%	20,218	3/31/2022
2021 Q4	2/11/2022	2,213	0.0%	16,901	12/31/2021
2021 Q3	11/12/2021	1,898	0.0%	15,513	9/30/2021
2021 Q2	8/12/2021	1,629	0.0%	14,282	6/30/2021
2021 Q1	5/12/2021	1,214	0.0%	10,101	3/31/2021
2020 Q4	2/19/2021	724	0.0%	7,125	12/31/2020
2020 Q3	11/12/2020	465	0.0%	5,889	9/30/2020
2020 Q2	8/11/2020	582	0.0%	5,228	6/30/2020
2020 Q1	5/12/2020	244	0.0%	3,387	3/31/2020
2019 Q4	2/11/2020	113	0.0%	1,503	12/31/2019